Local News Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T Cell Receptors Associated with Crohn’s Disease Adaptive Biotechnologies | February 24, 2022 Adaptive Biotechnologies, a commercial-stage biotechnology company that aims to translate the genetics of the adaptive…dcorriganFebruary 24, 2022 Read More
Local News Meet Princess Imoukhuede UW Department of Bioengineering | February 24, 2022 On Jan. 1, Princess Imoukhuede joined UW as the Hunter and Dorothy Simpson Endowed Chair and Professor…dcorriganFebruary 24, 2022 Read More
Local News Magnolia Medical Announces $46 Million Growth Equity Financing Magnolia Medical Technologies | February 23, 2022 Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to…dcorriganFebruary 23, 2022 Read More
Local News MRI May Lower Breast Cancer Death from Variants in Three Genes UW Medicine | February 22, 2022 Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more…dcorriganFebruary 22, 2022 Read More
Local News UW/Fred Hutch CFAR Announces New Co-Director of the Center & New Director of the Biometrics Core UW/Fred Hutch Center for AIDS Research | February 18, 2022 The UW/Fred Hutch Center for AIDS Research (CFAR) has announced that their search process for…dcorriganFebruary 18, 2022 Read More
Local News The ‘Golden Age’ for Research Tools: Parse Biosciences Raises $41.5M for Single-Cell Tech GeekWire | February 17, 2022 Alex Rosenberg was a postdoc at the University of Washington when he co-founded a new biotech…dcorriganFebruary 17, 2022 Read More
Local News Davis Lab Examines a Protein With a Key Role in Scarring Institute for Stem Cell & Regenerative Medicine | February 17, 2022 When an injury occurs, the body reacts immediately. Cells in the vicinity of the trauma…dcorriganFebruary 17, 2022 Read More
Local News Astellas and Seagen Announce Initial Results of PADCEV® (Enfortumab Vedotin-Ejfv) in Patients with Muscle-Invasive Bladder Cancer Not Eligible for Cisplatin Chemotherapy Seagen | February 16, 2022 Astellas Pharma US and Seagen, Inc. announced the initial results from Cohort H of the EV-103…dcorriganFebruary 16, 2022 Read More
Local News ‘Closing the Gap’ Paper Examines BBI’s Progress Toward Resolving Genetic Variants of Unknown Significance Brotman Baty Institute | February 16, 2022 Shawn Fayer was in a coffee shop in Boston in 2017 when he read those…dcorriganFebruary 16, 2022 Read More
Local News Curevo Nets $60M for Adjuvant-Saving Shingles Vaccine BioSpace | February 11, 2022 Curevo Vaccine has secured $60 million in Series A financing. Curevo, a clinical-stage biotechnology company, is developing…dcorriganFebruary 11, 2022 Read More